Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci.

PubWeight™: 1.55‹?› | Rank: Top 4%

🔗 View Article (PMID 3766492)

Published in Am J Dis Child on November 01, 1986

Authors

K P Klugman, H J Koornhof, V Kuhnle

Articles citing this

Pneumococcal resistance to antibiotics. Clin Microbiol Rev (1990) 9.76

Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother (1996) 8.65

Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob Agents Chemother (1992) 3.39

Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 1.66

Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa. Antimicrob Agents Chemother (2001) 1.60

Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. Emerg Infect Dis (1998) 1.17

Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population. Bull World Health Organ (1997) 1.03

Epidemiology, control and treatment of multiresistant pneumococci. Drugs (1996) 1.00

Reporting Emerging Resistance of Streptococcus pneumoniae from India. J Glob Infect Dis (2010) 0.96

Fatal infection caused by a multiply resistant type 3 pneumococcus. J Clin Microbiol (1988) 0.94

Pneumococcal carriage in sub-Saharan Africa--a systematic review. PLoS One (2014) 0.85

Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide. J Clin Microbiol (1991) 0.83

Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective. Clin Microbiol Rev (2016) 0.82

Antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Lesotho. Bull World Health Organ (1998) 0.76

Carriage of penicillin resistant pneumococci. Arch Dis Child (1988) 0.75

Incidence of bacterial respiratory pathogens and their susceptibility to common antibacterial agents. J Natl Med Assoc (1993) 0.75

Articles by these authors

Emergence of multiply resistant pneumococci. N Engl J Med (1978) 8.32

Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol (2001) 6.66

Detection of enteric campylobacteriosis in children. J Clin Microbiol (1979) 4.57

Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis (2000) 4.24

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol (2001) 4.19

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis (1999) 3.72

Generalized Yersinia enterocolitica infection. J Infect Dis (1975) 3.55

Outbreake of Marburg virus disease in Johannesburg. Br Med J (1975) 3.51

Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians (1976) 3.49

Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet (1992) 3.42

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09

Protective efficacy of pneumococcal polysaccharide vaccines. JAMA (1977) 2.83

Antimicrobial susceptibility testing of pneumococci. 2. Determination of optimal disc diffusion test for detection of penicillin G resistance. J Antimicrob Chemother (1980) 2.73

Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions. Antimicrob Agents Chemother (1985) 2.71

Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986. J Infect Dis (1988) 2.69

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet (1987) 2.59

Genetic diversity of penicillin-binding protein 2B and 2X genes from Streptococcus pneumoniae in South Africa. Antimicrob Agents Chemother (1993) 2.44

Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin. Antimicrob Agents Chemother (1979) 2.32

Enterotoxin production in relation to taxonomic grouping and source of isolation of Aeromonas species. J Clin Microbiol (1984) 2.27

Resistance mechanisms of multiply resistant pneumococci: antibiotic degradation studies. Antimicrob Agents Chemother (1979) 2.17

Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis (2000) 2.02

Alterations in PBP 1A essential-for high-level penicillin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 1.98

Lack of utility of serotyping multiple colonies for detection of simultaneous nasopharyngeal carriage of different pneumococcal serotypes. Pediatr Infect Dis J (2000) 1.87

Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis (2007) 1.87

Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneumoniae. Antimicrob Agents Chemother (1995) 1.82

Invasive potential of noncytotoxic enteropathogenic Escherichia coli in an in vitro Henle 407 cell model. Infect Immun (1989) 1.77

In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils. J Immunol (1976) 1.76

Spread of the Spanish multi-resistant serotype 23F clone of Streptococcus pneumoniae to Seoul, Korea. Microb Drug Resist (1997) 1.74

Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis (2011) 1.70

Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatr Infect Dis J (2000) 1.69

Evaluation of the Etest as a means of determining the antibiotic susceptibilities of isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in the Central African Republic. J Antimicrob Chemother (2000) 1.67

Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 1.66

Mechanism of action of Yersinia enterocolitica enterotoxin. Infect Immun (1979) 1.61

Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa. Antimicrob Agents Chemother (2001) 1.60

Corneal ulceration at an urban African hospital. Br J Ophthalmol (1985) 1.59

Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine (1996) 1.59

Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr (2000) 1.54

Community-acquired pneumonia due to penicillin-resistant pneumococci. N Engl J Med (1985) 1.54

Laboratory-based diagnosis of pneumococcal pneumonia: state of the art and unmet needs. Clin Microbiol Infect (2011) 1.54

A microbiological study of gastro-enteritis in Black infants. S Afr Med J (1977) 1.51

Efficacy of Vi polysaccharide vaccine against strains of Salmonella typhi: reply. Vaccine (1998) 1.51

Generalized infection with Yersinia enterocolitica and the role of iron. Contrib Microbiol Immunol (1979) 1.50

Campylobacter infections in Soweto. S Afr Med J (1979) 1.49

Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child (1992) 1.49

'Atypical' bacteria are a common cause of community-acquired pneumonia in hospitalised adults. S Afr Med J (1994) 1.46

Three predominant clones identified within penicillin-resistant South African isolates of Streptococcus pneumoniae. Microb Drug Resist (1997) 1.45

Letter: Viruses in acute summer gastroenteritis in black infants. Lancet (1975) 1.43

The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration. Clin Exp Immunol (1976) 1.43

Causes and treatment of sexually acquired genital ulceration in southern Africa. S Afr Med J (1989) 1.43

Pathogenic mechanisms of a non-agglutinable Vibrio cholerae strain: demonstration of invasive and enterotoxigenic properties. Infect Immun (1977) 1.43

Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis (1998) 1.42

Fecal bacteria in South African rural blacks and other population groups. Isr J Med Sci (1979) 1.42

In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus. Antimicrob Agents Chemother (1996) 1.42

Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (2001) 1.40

Epidemiology of rheumatic heart disease in black shcoolchildren of Soweto, Johannesburg. Br Med J (1975) 1.39

Letter: Nitroblue tetrazolium test (NBT) in the investigation of febrile patients. S Afr Med J (1973) 1.38

Factors associated with airway colonisation and invasion due to Klebsiella spp. S Afr Med J (1993) 1.38

The recent cholera outbreak in the South African gold mining industry. A preliminary report. S Afr Med J (1974) 1.37

Accuracy of clinical diagnosis of genital ulcer disease. Sex Transm Dis (1991) 1.35

A laboratory assessment of ciprofloxacin and comparable antimicrobial agents. Eur J Clin Microbiol (1984) 1.34

Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg. Antimicrob Agents Chemother (1982) 1.33

Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine. J Infect Dis (2000) 1.33

Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action. Antimicrob Agents Chemother (2000) 1.32

Yersinia enterocolitica infections in South Africa. S Afr Med J (1972) 1.31

Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis (1999) 1.28

Long-term survival of Streptococcus pneumoniae at room temperature on Dorset egg medium. J Clin Microbiol (1998) 1.26

Rapid detection of penicillin-resistant Streptococcus pneumoniae in cerebrospinal fluid by a seminested-PCR strategy. J Clin Microbiol (1998) 1.26

In vitro susceptibility and cross-resistance of South African isolates of Neisseria gonorrhoeae to 14 antimicrobial agents. Antimicrob Agents Chemother (1982) 1.26

Non-Penicillin-Binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae. Microb Drug Resist (2000) 1.24

Molecular basis of rifampin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (1999) 1.24

Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis (1997) 1.23

Bacteremia caused by a lactose-fermenting, multiply resistant Salmonella typhi strain in a patient recovering from typhoid fever. J Clin Microbiol (1987) 1.21

Neonatal septicemia and meningitis due to Aeromonas shigelloides. J Pediatr (1978) 1.21

Summer diarrhoea in African infants and children. Arch Dis Child (1980) 1.20

Carriage of penicillin resistant pneumococci. Arch Dis Child (1986) 1.20

Clostridium difficile colitis associated with the use of antineoplastic agents. Eur J Clin Microbiol (1984) 1.20

Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants. Antimicrob Agents Chemother (2000) 1.19

Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother (2001) 1.18

"Megaprimer" method of PCR-based mutagenesis: the concentration of megaprimer is a critical factor. Biotechniques (1997) 1.18

Defective neutrophil motility in children with measles. J Pediatr (1976) 1.17

Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. Emerg Infect Dis (1998) 1.17

Identification of the tetracycline resistance gene, tet(O), in Streptococcus pneumoniae. Antimicrob Agents Chemother (1996) 1.16

Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. J Antimicrob Chemother (1998) 1.13

In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur J Clin Microbiol Infect Dis (1992) 1.12

Age related susceptibility to Campylobacter jejuni infection in a high prevalance population. Arch Dis Child (1983) 1.12

Antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in the Central African Republic. Pediatr Infect Dis J (2000) 1.10

T and CR+ lymphocyte profile in leprosy and the effect of treatment. Infect Immun (1976) 1.10

Standardisation of the nitro-blue tetrazolium test and factors affecting its clinical application. S Afr Med J (1974) 1.10

Worldwide increase in pneumococcal antibiotic resistance. Lancet (1989) 1.08

The prevalence of antimicrobial resistance in human faecal flora in South Africa. Epidemiol Infect (1993) 1.08

Antibiotic-resistant pneumococci in hospitalized children. J Hyg (Lond) (1984) 1.08

Urinary tract infection with Corynebacterium urealyticum in South Africa. Eur J Clin Microbiol Infect Dis (1993) 1.07

Neonatal typhoid fever. Pediatr Infect Dis J (1994) 1.07

The Widal test in the diagnosis of typhoid fever in the transvaal. S Afr Med J (1981) 1.07

Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. J Antimicrob Chemother (1994) 1.07

Etiology of infantile enteritis in South Africa. Isr J Med Sci (1979) 1.07

In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens. Antimicrob Agents Chemother (1986) 1.05

Acquisition of chloramphenicol resistance by the linearization and integration of the entire staphylococcal plasmid pC194 into the chromosome of Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 1.05